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Retinol and retinyl esters are converted with time to
slowly increasing amounts of all-trans retinoic acid
(RA) in cultured human keratinocytes. Exogenous RA
has been shown to limit retinol oxidation and to
increase retinol esterification. Because significant
amounts of retinol are present in biologic systems,
we examined whether RA and all-trans-retinoyl-b-D-
glucuronide (RAG) interact with retinol in exhibiting
their activities on HaCaT keratinocytes maintained in
a retinoid-free culture system. RA was more potent
than RAG and retinol in inducing ultrastructural
changes attributed to retinoids, inhibiting cell prolif-
eration as well as enhancing keratin 19 expression. In
addition, retinoids were able to induce cellular retinoic
acid-binding protein II mRNA levels in the cultures,
whereas early RA and late RAG activity was detected.
The described biologic effects of RA and RAG were
diminished by simultaneous cell exposure to retinol.
HaCaT cells quickly metabolized retinol to retinyl
esters and consequently to low amounts of RA. RA
treatment led to an early high peak of cellular RA
followed by reduction to trace amounts. Treatment
Human skin requires retinol for regulation ofkeratinocyte growth and differentiation (Fuchs,1990; Darmon, 1991). The biologic activity ofretinol is considered to be predominantly exhibitedby its natural oxidation product, all-trans retinoic
acid (RA) (Kurlandsky et al, 1994). Excess retinol is mainly handled
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with RAG resulted in constantly high cellular RAG
and low RA levels. Under the combined RA and
retinol treatment retinyl esters were increased and RA
was reduced in HaCaT cells, whereas extracellular RA
levels were similar to those obtained by RA alone. On
the other hand, the combination of RAG and retinol
resulted in higher extracellular RAG, similar cellular
RAG, and lower cellular RA levels than those obtained
by RAG alone without any change in retinyl esters.
This study demonstrates that retinoid signaling by RA
and RAG is attenuated by simultaneous exposure of
HaCaT keratinocytes in vitro to retinol. The presence
of retinol in the medium alters the rate of RA or RAG
metabolism and thus cellular RA concentrations. The
intensity of retinoid signal is probably dependent on
cellular RA levels. The resulting ‘‘antagonism’’ among
retinoids is consistent with the presence of an auto-
regulatory mechanism in human keratinocytes offering
protection against excessive accumulation of cellular
RA. Key words: cell proliferation/CRABP II/HaCaT/
keratin 19/retinoid-free culture/retinoid metabolism. J Invest
Dermatol 112:157–164, 1999
by human and mouse epidermis in vivo by ester formation (Kang
et al, 1995; Sass et al, 1996).
On the other hand, synthetic RA and other retinoids have been
successfully used for treatment of various epidermal disorders
(Zouboulis et al, 1995; Orfanos et al, 1997). RA binds to and
induces cellular retinoic acid-binding protein II (CRABP II) as
well as binds to and activates nuclear retinoic acid receptors
(Gigue`re, 1994; Ross and Gardner, 1994). Most actions of RA are
now recognized to be mediated through activation of retinoic acid
receptors. Epidermal keratinocytes in vivo probably regulate their
RA levels by induction of RA 4-hydroxylase (Duell et al, 1992).
RA inactivation by 4-hydroxylation prevents RA accumulation in
the epidermis during application of retinoids to human skin and
leads to cellular RA concentrations of 20 nM or lower (Kang et al,
1995; Duell et al, 1996), which seem to be optimal for a normal
pattern of keratinocyte differentiation (Asselineau et al, 1989).
Recent work showed that retinol, retinaldehyde, 9-cis retinoic
acid, and 13-cis retinoic acid are not able to regulate their own
hydroxylation and that only RA induces its own inactivation by
RA 4-hydroxylase (Duell et al, 1996).
In contrast to the findings on human skin in vivo, RA metabolism
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in human keratinocytes maintained in serum-containing cultures is
robust and is not further induced by the addition of exogenous
RA (Randolph and Simon, 1997). This extensive RA metabolism
proceeds without detectable levels of 4-hydroxy RA. It is still
unknown whether this metabolic pathway, i.e., multiple sequential
enzymatic reactions, involves 4-hydroxylase activity, but retinol
and retinyl esters can be converted with time to slowly increasing
amounts of RA (Randolph and Simon, 1993; Kurlandsky et al,
1994). In addition, significant amounts of retinol are present in
biologic systems (Gigue`re, 1994). Therefore, the effects of exogen-
ous and endogenous RA on human keratinocytes in vitro can be
hardly discriminated in common culture systems. In this study we
developed a simple retinoid-free culture system for epithelial cells
to examine whether RA and all-trans retinoyl-β-D-glucuronide
(RAG), a natural RA derivative (Dunagin et al, 1965), may interact
with retinol in exhibiting their activities on human keratinocytes
in vitro. Bovine serum albumin (BSA) was shown to be a key
molecule in this model. The spontaneously immortalized, nontumo-
rigenic human HaCaT keratinocytes were used instead of normal
human keratinocytes in our studies because HaCaT cells (i) could
be maintained in a defined retinoid-free culture system described
below providing reproducible results, and (ii) present a similar
differentiation pattern to normal keratinocytes (Schu¨rer et al, 1993)
and have been successfully used in several pharmacologic studies
in vitro (Jeffes et al, 1995; Lehmann, 1997; Stein et al, 1997). We
found that the biologic effects of RA and of RAG on human
keratinocytes in vitro are diminished by simultaneous exposure of
the cells to retinol. Enhanced or decreased activity of retinoids was
associated with increased or reduced cellular RA, respectively.
Moreover, we demonstrated that retinoids can induce CRABP II
mRNA in retinoid-free cultured human keratinocytes.
MATERIALS AND METHODS
Cell cultures The spontaneously immortalized, nontumorigenic human
keratinocyte line HaCaT was kindly provided by Prof. N.E. Fusenig
and Dr. D. Breitkreutz (German Cancer Research Center, Heidelberg,
Germany) (Boukamp et al, 1988) and was cultured in Dulbecco’s modified
Eagle’s (DME)/Ham’s F 12 medium (1:1; Gibco, Berlin, Germany)
supplemented with 10% fetal calf serum, 1.4 mM L-glutamine, 100 IU
penicillin per ml, and 100 µg streptomycin per ml (all Seromed, Berlin,
Germany) with 5% CO2 at 37°C. For all studies passages between 50 and
100 were used. Before performing the experiments, HaCaT cells have
been accustomed to diminished fetal calf serum concentrations and have
been finally subcultivated five times in serum-free DME/Ham’s F 12
medium only supplemented with L-glutamine and antibiotics.
Treatment with BSA and retinoids BSA (Boehringer, Mannheim,
Germany) was dissolved in serum-free DME/Ham’s F 12 medium to give
concentrations from 0.16 to 40 mg per ml. Retinol (Sigma, Deisenhofen,
Germany) was dissolved in dimethyl sulfoxide (DMSO; Merck, Darmstadt,
Germany) and subsequently in serum-free DME/Ham’s F 12 medium with
or without BSA (1 mg per ml), giving final concentrations from 10–13 to
10–5 M retinol and 0.2% DMSO. RA (gift of Hoffmann-La Roche, Basel,
Switzerland) and RAG were dissolved in DMSO and subsequently in
serum-free DME/Ham’s F 12 medium supplemented with 1 mg BSA per
ml, giving final retinoid concentrations from 10–12 to 10–6 M and 0.2%
DMSO. RAG was synthesized following a modification (Foerster et al,
1996) of the method described by Barua and Olson (1989). All chemicals
for RAG synthesis were a gift of BASF AG (Ludwigshafen, Germany).
0.2% DMSO alone served as control. Retinoids were handled under dim
amber light.
Morphologic studies The morphology of HaCaT cells was evaluated
by inverted photomicroscopy and electron microscopy. For transmission
electron microscopic examination, HaCaT cell cultures were grown to
confluence on plastic Lux Thermanox cover slips (Miles Laboratories,
Naperville, IL) and were processed using standard techniques (Detmar
et al, 1989).
Cell proliferation HaCaT cells were maintained in 96 well culture
plates (Falcon, Jersey, NJ). Cell proliferation was assessed by the
4-methylumbelliferyl heptanoate fluorescence assay and measured automat-
ically, as described before (Stadler et al, 1989; Zouboulis et al, 1991). On
the day of evaluation culture medium was removed, the cells were washed
twice with phosphate-buffered saline without Ca21 and Mg21 (pH 7.2,
Seromed), and 100 µl of a 100 µg 4-methylumbelliferyl heptanoate (Serva,
Heidelberg, Germany) per ml solution in phosphate-buffered saline were
added to each well. The plates were then incubated for 30 min at 37°C
and their fluorescence was read on a Titertek Fluoroscan II (Flow,
Meckenheim, Germany). The results are given as absolute fluorescence
units using 355 nm excitation and 460 nm emission filters.
High pressure liquid chromatography (HPLC) Retinol and its
metabolites were analyzed in HaCaT cells and in collected supernatants by
a reverse-phase HPLC method according to Collins et al (1992), which
provides a single run analysis of both polar retinoids, i.e., RA, RAG, and
their isomers, and nonpolar retinoids, i.e., retinol and retinyl esters. Sample
enrichment by solid phase extraction preceded HPLC analysis with the
exception that butylated hydroxytoluene was omitted. If below 100 mg,
the weight of cell samples was adjusted to this value by addition of water.
One hundred milligrams cell preparation were homogenized in 300 µl
isopropanol (Merck), using a Branson B-12 sonifier (Danbury, CT). In
contrast to the described method, only 300 µl of the tissue supernatant
were diluted 3-fold with 2% ammonium acetate (Merck) solution and
submitted to solid phase extraction. Adjustment of the eluent pH was not
necessary for our samples and the internal standard was omitted as done
by Eckhoff et al (1990). In all experiments, retinoids were identified by
comparison with retention times and ratios of absorbance units at the two
detection wavelengths (340/356 nm) of reference compounds, which were
determined simultaneously with a Shimadzu SPD-10A detector (Kyoto,
Japan). Multilinear calibration was performed by analysis of solutions of
5% (wt/vol) BSA in phosphate-buffered saline (Merck), which had been
spiked with known amounts of retinoids. Polar reference retinoids were a
gift of Hoffmann-La Roche. Retinyl palmitate was purchased from Sigma.
Synthesis of retinyl esters was previously described by Eckhoff et al (1989).
Northern analysis of human CRABP II mRNA levels Total RNA
was isolated from subconfluent HaCaT cells using a commercial kit
(RNAzol; WAK-Chemie, Bad Homburg, Germany) and stored at –70°C
until use. RNA concentrations were determined by absorbance at 260 nm
and verified by nondenaturing agarose gel electrophoresis and ethidium
bromide staining (Thompson et al, 1985). Thirty micrograms of total RNA
were size-fractionated by electrophoresis in 1% formaldehyde-agarose gels
containing 0.2 µg ethidium bromide per ml and transferred to derivatized
nylon membranes (GeneScreenPlus; NEN, Dreieich, Germany) (Elder
et al, 1990). Complete transfer of RNA was documented by examining
the gels under ultraviolet light. The blots were sequentially hybridized
against CRABP II and β-actin cDNA probes labeled to a specific activity
of 3 3 109 cpm DNA per µg with 32P-dCTP (Amersham, Braunschweig,
Germany) by the random priming technique (Feinberg and Vogelstein,
1983) at a concentration of 4 3 105 cpm hybridization buffer per ml. The
CRABP II probe was a purified insert fragment from human CRABP II
cDNA (Åstro¨m et al, 1991), which was kindly provided by Dr. A. Tavakkol
(Colgate-Palmolive, Piscataway, NJ). The β-actin probe was a gift of Dr. J.
Eberle of our Department of Dermatology. The prehybridization and
hybridization procedures are described elsewhere (Åstro¨m et al, 1991).
Northern blots were visualized by screen-enhanced autoradiography per-
formed by exposing Kodak X-OMAT AR films (Kodak, Rochester, NJ)
to the blots in Kodak X-Omatik Regular cassettes in the presence of
intensifying screens (Kodak) at –70°C for 24 h. The films were developed
in a Kodak M6B RP X-Omat processor.
Gel electrophoresis of keratin-enriched protein fractions HaCaT
cells were grown to confluency in 100 mm culture dishes (Falcon) prior
to treatment with the test substances. The cells were then manually scrapped
from the culture dishes, harvested into centrifuge tubes, homogenized, and
extracted as described (Mischke and Wild, 1987). The resulting pellet,
highly enriched in cytoskeletal proteins, was solubilized in sample buffer.
One-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (SDS-PAGE) according to Laemmli (1970) was performed as described
(Mischke and Wild, 1987). Gels were stained in 0.2% Coomassie blue
(Serva-Blue R; Serva).
Quantitation of mRNA and keratin levels For quantitation of mRNA
and keratin levels a computed-assisted image analysis system (Bio-Profil,
Vilber Lourmat, Marne La Valle´e, France) was used. In northern analysis,
the intensity of CRABP II mRNA levels was normalized to
β-actin, which was used as control gene, by dividing the signal intensity
obtained for CRABP II with that of β-actin. The results of the western
analysis obtained by SDS-PAGE were presented as keratin 19/total protein
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Figure 1. Detection of optimum proliferation of HaCaT cells under
serum-free conditions. (a) Optimum proliferation of HaCaT cells grown
in 10% fetal calf serum (SF 1 FCS 10%), 0.8–1 mg BSA per ml (SF 1 BSA),
and serum-free medium (SF) in 96 well culture plates was obtained at a
seeding density of 2000 cells per well. AFU, absolute fluorescence units.
(b) Exponential growth of HaCaT cells for 96 h in serum-free medium
supplemented with different concentrations of BSA. There was a 3.9 times
decreased growth in serum-free control (Con.) compared with cells grown
in 10% fetal calf serum; cell growth was normalized by addition of 0.31–
5 mg BSA per ml. The results are presented as mean values of six samples,
error bars represent SD. dAFU, difference of the AFU values between 96
and 0 h, representing proliferating cells. *p , 0.05; **p , 0.01.
volume, because keratin 19 is known to be upregulated by retinoids (Korge
et al, 1990).
Statistical analysis The results are presented as mean values, error bars
represent SD. In proliferation experiments, each mean value represents six
or 10 samples. In northern analysis and in HPLC analysis of retinoid levels
in medium, each mean value represents three samples. In western analysis
and HPLC studies of cellular retinoids three samples were pooled to give
a single value. Statistical comparisons were performed by Student’s t test
using a two-tailed hypothesis. Differences were defined as statistically
significant at p , 0.05.
RESULTS
Establishment of a defined retinoid-free culture system for
retinoid studies on HaCaT cells in vitro Assessment of the
influence of the seeding density (125–3000 cells per well in a 96
well culture plate) on HaCaT cell proliferation revealed that 2000
cells per well produced an optimum exponential growth for cells
grown in medium containing 10% fetal calf serum, 0.8–1 mg BSA
per ml, and in serum-free medium (Fig 1a). In addition, the
decreased rate of HaCaT cell proliferation in serum-free medium
(26% of the proliferation rate obtained in medium containing 10%
fetal calf serum at 96 h) was almost normalized by 0.31–5 mg BSA
Figure 2. Morphology of HaCaT cells maintained at different
culture conditions. (a) HaCaT cells cultured in serum-free medium
exhibited a mostly spindle-shaped morphology. Epithelial morphology was
reestablished into 48 h after addition of (b) 10% fetal calf serum, (c) 1 mg
BSA per ml, (d) 1 mg BSA per ml 1 retinol 10–8 M, but not after
addition of (e) retinol 10–8 M. Scale bar: 400 µm.
Figure 3. Proliferation of HaCaT cells for 96 h in serum-free
medium supplemented with different concentrations of retinol and
combined retinol and 1 mg BSA per ml. Medium was renewed
every 2 d. Retinol (ROL) added in serum-free medium was inactive at
concentrations of 10–13–10–7 M, only inhibited cell proliferation at
10–6 M, and was toxic at 10–5 M. Retinol added in BSA-supplemented
medium exhibited a dose-dependent inhibition of HaCaT cell proliferation
at concentrations of 10–9–10–5 M (14%–82% at 96 h). The results are
presented as mean values of six samples, error bars represent SD. Con.,
serum-free control; BSA, BSA-supplemented control; dAFU, difference of
the AFU values between 96 and 0 h, representing proliferating cells.
**p , 0.01; ***p , 0.001.
per ml (Fig 1b). HaCaT cells that became spindle-shaped under
serum-free conditions reestablished their epithelial morphology in
BSA-supplemented medium with or without retinol, but not in
only retinol-supplemented medium (Fig 2). Under serum-free
conditions retinol was inactive on HaCaT cell proliferation at
concentrations of 10–13–10–7 M, only inhibited cell proliferation
at 10–6 M, and was toxic for HaCaT cells at 10–5 M (Fig 3). In
contrast, a dose-dependent inhibition of HaCaT cell proliferation
was detected at concentrations of 10–9–10–5 M [14%–82% at 96 h,
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Figure 4. Electron microscopy of
serum-free confluent HaCaT cell
cultures treated with retinoids for 7 d.
In comparison with the untreated control
(a), shortening and rarefication of
desmosomes (open arrowheads), formation of
numerous microvilli on both the free and
the internal cell surfaces (*), widening of
the intercellular spaces (1), and formation
of structures reminiscent of canaliculi
(arrows) were observed under retinol 10–8
M (b), RA 10–10 M (c), and RAG 10–8 M
(d) treatment. Under RA 10–8 M (e) loss of
microvilli, remnants of desmosome plaques
(closed arrowheads), and loss of cell-to-cell
contact were apparent. Scale bars: 0.2 nm.
50% inhibitory concentration (IC50) µ 10
–7 M] when retinol has
been added in BSA (1 mg per ml)-supplemented medium.
Effects of retinoids on cell ultrastructure Confluent HaCaT
cell cultures treated for 7 d with retinol 10–8 M, RA 10–10 M, and
RAG 10–8 M exhibited shortening and rarefication of desmosomes,
formation of numerous microvilli on both the free and the internal
cell surfaces, widening of the intercellular spaces and formation of
structures reminiscent of canaliculi, when compared with the
untreated controls (Fig 4). Under RA 10–8 M the observed retinoid
effects were magnified: cell membrane retraction and loss of
microvilli, remnants of desmosome plaques, and loss of cell-to-cell
contact were apparent.
Effects of retinoids on HaCaT cell proliferation The activity
of retinoids on the proliferation of HaCaT cells was investigated
by two experimental protocols: (i) application of a single retinoid
concentration (10–7 M) for increasing duration without medium
and retinoid renewal, and (ii) continuous application of retinoids
in increasing concentrations with renewal of medium and retinoids
every 48 h. After application of retinol for 6, 12, 24, 48, 72, 96,
and 120 h without renewal, no change of cell proliferation was
found during a period of 120 h (Fig 5). In contrast, short treatment
with RA over 6 h inhibited cell proliferation for at least 120 h
(82% 6 3% inhibition, p , 0.001) in a similar magnitude with
RA treatment for 120 h. Combined RA/retinol treatment did not
influence the anti-proliferative RA activity (83% 6 2% inhibition).
On the other hand, RAG required 120 h to exhibit maximum
inhibition of cell proliferation (68% 6 2%), whereas simultaneous
RAG/retinol treatment decreased RAG effectivity by 13%
(p , 0.001).
Under continuous treatment and retinoid renewal every 48 h,
RA and RAG showed a narrow concentration range where they
developed anti-proliferative effects. RA IC50 was 10
–9.5 M and
RAG IC50 about 10
–8.5 M at 120 h. Simultaneous RA/retinol
(10–6 M) and RAG/retinol (10–6 M) treatment exhibited weaker
anti-proliferative effects than RA and RAG alone, respectively
(RA/ROL IC50 5 10
–8 M, p , 0.001; RAG/ROL
IC50 . 10
–8 M, p , 0.001).
Retinoid metabolism Metabolic studies were performed in
retinoid-treated HaCaT cell cultures without renewal of the culture
medium in which retinoids were applied at the onset of the
incubation period. Analysis of cells treated with 10–7 M retinol
revealed quick cellular retinol uptake and esterification. At 6 h
retinol was not detectable in the medium and even the sum of
cellular concentrations of retinol and 3,4-didehydro-retinol stayed
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Figure 5. Proliferation of serum-free HaCaT cells for 120 h without
renewal of retinoids every 48 h. After treatment for 6 and 120 h retinol
(ROL, 10–7 M) was practically inactive. In contrast, a 6 h RA treatment
(10–7 M) inhibited proliferation for at least 120 h with or without presence
of retinol (10–7 M). RAG (10–7 M) required 120 h to exhibit maximum
inhibition of HaCaT cell proliferation, whereas simultaneous RAG/retinol
(10–7 M) treatment decreased RAG effectivity. The results are presented
as mean values of 10 samples, error bars represent SD. dAFU 5 difference
of the AFU values between 120 and 0 h, representing proliferating cells.
***p , 0.001.
Figure 6. HPLC analysis of cellular retinyl esters under 96 h
treatment with retinol, RA/retinol, and RAG/retinol. High levels
of retinyl esters that decreased with time were obtained at 6 h. Under the
combined RA (10–7 M)/retinol (10–7 M) treatment retinol esterification
was increased compared with the treatment with retinol alone. Under the
combined RAG (10–7 M)/retinol (10–7 M) treatment retinol esterification
did not change compared with retinol (10–7 M) alone. Single values
represent results of three pooled samples. Retinyl esters 16:0/18:1 5 retinyl
palmitate/retinyl oleate, retinyl ester 14:0 5 retinyl myristate.
below the retinol concentration that was initially added to the
culture medium. Cellular retinol concentration further declined
with time, whereas only small amounts of RA were found in the
cells (,20–30 nM). On the other hand, high cellular levels of
retinyl esters were obtained at 6 h [1754 nM retinyl palmitate
(16:0)/retinyl oleate (18:1) and 297 nM retinyl myristate (14:0)]
(Fig 6). Further unknown retinol metabolites, probably didehydro-
retinyl esters, were also detected in high levels (several 100 nM).
Like retinol, cellular retinyl esters decreased with time. Treatment
with RA (10–7 M) resulted in high cellular RA levels in short
time, being 21-fold higher than the initial medium concentration
at 6 h (1724 nM). In parallel, only µ1/4 of the initial RA
concentration was detected in the medium at 6 h (RA half life in
medium , 6 h) (Table I); however, already at 24 h, only trace
RA amounts were detected in the cells and in the medium (,20–
30 nM). Treatment with 10–7 M RAG led to a cellular level of
Table I. HPLC analysis of extracellular RA and RAG
levels under treatment with RA versus RA/retinol and
RAG versus RAG/retinola
Extracellular RA levels under Extracellular RAG levels under
treatment with treatment with
RA (10–7 M)/ RAG (10–7 M)/
RA retinol RAG retinol
(10–7 M) (10–7 M) p (10–7 M) (10–7 M) p
6 h 27% 6 4% 27% 6 5% nsb 78% 6 4% 95% 6 2% ,0.01
24 h ndb nd 67% 6 2% 77% 6 2% ,0.01
48 h nd nd 58% 6 4% 66% 6 5% ns
96 h nd nd 54% 6 2% 62% 6 1% ,0.01
a The results are presented in percentage of the initial medium concentration
(mean values of three samples 6 SD).
b nd, concentration under the detection levels; ns, not significant.
46-fold its initial medium concentration (6 h) and showed, in
contrast to RA, a slow decline in the cells and in the medium
(RAG half life in medium µ 96 h). In addition, low cellular RA
levels presented after incubation with RAG (,30 nM).
Under the combined RA (10–7 M)/retinol (10–7 M) treatment
the amounts of cellular retinol and 3,4-didehydro-retinol did not
significantly change, but esterification was increased (2510 nM
retinyl palmitate/retinyl oleate and 464 nM retinyl myristate at
6 h) compared with treatment with retinol alone (Fig 6). Whereas
RA amounts in medium did not change (RA half life in medium
, 6 h) (Table I), cellular RA amounts were halved at 6 h (701 nM)
compared with those under cell treatment with RA alone. Under
the combined RAG (10–7 M)/retinol (10–7 M) treatment retinol
esterification did not change as compared with the treatment with
retinol alone (Fig 6). Cellular RAG levels were only increased at
6 h (59-fold its initial medium concentration) but were similar to
those obtained by RAG alone at 24–96 h. RAG levels in medium
were increased compared with RAG alone (p , 0.01) (RAG half
life in medium . 96 h) (Table I), and cellular RA was decreased.
RA isomerization to 13-cis retinoic acid and 9-cis retinoic acid
and RAG isomerization to 13-cis retinoyl-β-D-glucuronide and 9-
cis retinoyl-β-D-glucuronide was observed in the medium and in
the cells, and it remained unaffected by combined treatments (data
not shown).
Effects of retinoids on CRABP II mRNA levels RA exhibited
stronger induction of CRABP II mRNA (10–6 M, 126 6 11 times
higher levels compared with the control, p , 0.001) than RAG
(10–6 M, 18 6 18 times higher, ns), and retinol (10–6 M, 5.4 6 9.3
times higher, ns) at 8 h (Fig 7a, b). In contrast, at 48 h RAG and RA,
but not retinol, induced CRABP II mRNA levels (RAG . RA; RA
10–6 M, 3.7 6 0.9 times higher, p , 0.05; RAG 10–6 M, 8.3 6 2.2
times higher, p , 0.01; retinol 10–6 M, 2.7 6 2.3 times higher,
ns) (Fig 7a, c). Combined RA/retinol (10–8 M) treatment strongly
induced CRABP II mRNA levels at 8 h (110 6 10 times higher
compared with control), whereas combined RAG/retinol
(10–8 M) treatment exhibited a maximum increase of CRABP II
mRNA levels at 48 h (6.7 6 2.4 times higher compared with
control). It is noticeable that there was an intrinsic induction of
CRABP II mRNA levels in HaCaT cells with culture duration,
because 20 6 18 times higher CRABP II mRNA levels were
assessed in the 48 h control than in the 8 h control.
Effects of retinoids on keratin 19 SDS-PAGE of keratins after
96 h of retinoid treatment showed weak enhancement of keratin
19 expression in HaCaT cells by RA (2.4 times higher at 10–6 M
in comparison with control), RAG (1.5 times higher at 10–6 M),
and retinol (1.5 times higher at 10–6 M) (Fig 8). Under the
combined RA (10–6 M)/retinol (10–8 M) and RAG (10–6 M)/
retinol treatments keratin 19 levels were lower (1.5 times higher
and ,1 times higher compared with control) that under RA and
RAG alone, respectively.
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Figure 7. Northern analysis of CRABP II mRNA levels. (a) CRABP
II mRNA levels after 8 and 48 h of treatment with retinol (ROL), RA,
RAG, and combined treatments. Assessment of CRABP II mRNA levels
at 8 h (b) and 48 h (c). The intensity of CRABP II was normalized to
β-actin. RA without or with retinol markedly induced CRABP II mRNA
levels at 8 h, RAG without or with retinol at 48 h. The results are
presented as CRABP II/β-actin ratios, mean values of three samples are
shown (mean value ratio of the control samples at 8 h 5 1), error bars
represent SD. *p , 0.05, **p , 0.01, ***p . 0.001.
DISCUSSION
In this study we found that retinoid signaling by RA and RAG
on human keratinocytes in vitro is attenuated by simultaneous
exposure of the cells to retinol. The combined treatments with
RA/retinol or RAG/retinol were less potent than RA or RAG
alone in (i) inhibiting cell proliferation, (ii) exhibiting an early
induction of CRABP II mRNA levels, and (iii) stimulating keratin
19 expression. The combined RA/retinol treatment was associated
with increased retinyl esters, the storage form of retinol, and lower
amounts of RA in the cells compared with RA levels detected
under treatment with RA alone. The combined RAG/retinol
Figure 8. Evaluation of keratin 19 expression. (a) SDS-PAGE of
HaCaT cell keratins after 96 h of treatment with retinol (ROL), RA,
RAG, and combined treatments. Gels were visualized by Coomassie blue.
(b) Assessment of keratin 19 induction by retinoids. RA induced keratin
19 expression more than RAG and retinol. Induction by combined
treatments was lower than that of the single agents. The results are presented
as keratin 19/total protein volume ratios. Single values represent results of
three pooled samples (ratio of the control samples 5 1).
treatment resulted in higher cellular RAG and lower RA levels in
comparison with the levels obtained under treatment with RAG
alone. We could demonstrate that the mechanism by which retinol
attenuates the retinoid signal generated by exogenous RA or RAG
is, in fact, a cellular event; it does not result by the stabilization or
retention of RA outside of cells in the culture medium under the
combined treatments. According to our data, the presence of retinol
in the medium alters the rates of cellular RA or RAG metabolism
and thus cellular RA concentrations.
In vivo, systemic treatment with RA in rats and with N-(4-
hydroxyphenyl)retinamide in humans has been shown to reduce
retinol plasma levels (reviewed in Vahlquist and To¨rma¨, 1991);
however, it was only in recent years that investigators provided
evidence of exogenous retinoid influence on endogenous retinol
metabolism in human skin. The findings of Rollman and Vahlquist
(1986), who showed that human skin reacts with increased retinol
concentrations following systemic treatment with 13-cis retinoic
acid, were confirmed by the detection of retinol accumulation after
treatment of cultured human skin with several retinoids (Vahlquist
and To¨rma¨, 1991). Concerning exogenous RA, it seems that it
regulates its own biosynthesis in human keratinocytes by modifying
retinol metabolism (Didierjean et al, 1996; Kurlandsky et al, 1996;
Randolph and Simon, 1996).
Like in previous reports (Randolph and Simon, 1993; Kurlandsky
et al, 1994), our cells rapidly took up and initially converted retinol
to retinyl esters and then with time to low amounts of RA. 3,4-
Didehydro-retinol was also detected (Rollman et al, 1993; Randolph
and Simon, 1993). Ester formation, especially of retinyl oleate
(18:1) and retinyl palmitate (16:0), remains the main root by which
excess retinol is handled by human keratinocytes in vitro (Randolph
and Simon, 1993; Rollman et al, 1993; Kurlandsky et al, 1994).
RA exhibited earlier and stronger biologic activity on the cells
than retinol, probably due to its early high cellular accumulation
and its less rapid metabolism, as currently reported (Randolph and
Simon, 1997). These findings support the assumption that the
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intensity of retinoid signaling is dependent, in part, on the quantity
of cellular RA. Retinoids were less biologically effective when
applied simultaneously with retinol, probably due to decreased RA
release and/or increased RA elimination from cells. This kind of
‘‘antagonism’’ is consistent with the presence of a tight auto-
regulatory mechanism in human keratinocytes offering protection
against excessive accumulation of cellular RA (Vanden Bossche
et al, 1988; Siegenthaler and Saurat, 1991).
RAG was shown to be formed in mouse skin via the RA
metabolic pathway (Didierjean et al, 1996) and was included in
our investigation because it is biologically active without significant
binding to either CRABP II or retinoic acid receptors (Mehta et al,
1992; Sani et al, 1992). The detection of low RA amounts in
RAG-treated keratinocytes confirms previous findings of a slow
rate of RAG hydrolysis to RA (Sani et al, 1992; Gunning et al,
1993). This finding together with the late maximum inhibition of
cell proliferation by RAG and the later induction of CRABP II
mRNA levels by RAG as compared with RA, despite the quick
accumulation of high RAG amounts in the cells during the entire
treatment period, suggest that RAG represents a precursor for RA
that also exhibits its activity by continuous release of low RA
amounts (Sass et al, 1997). On the other hand, although the
combined RAG/retinol regimen did not influence retinol ester-
ification, increased RAG amounts were found in the medium as
compared with the treatment with RAG alone. This finding
suggests that keratinocytes may respond to RAG by limiting RAG
metabolism to RA under the simultaneous RAG/retinol treatment.
The considerable amounts of retinol contained in fetal calf serum
(Fuchs and Green, 1981; Zouboulis et al, 1993), the depletion of
several lipid-soluble molecules other than retinoids by fetal calf
serum delipidization, which may affect retinoid metabolism
(Randolph and Simon, 1995), and the lack of retinoid transport
proteins in defined serum-free media accentuate the requirement
of a retinoid-free culture system for retinoid studies in vitro. BSA
added to our serum-free medium not only served as a transport
protein for retinol and RA (Noy and Xu, 1990; Noy, 1992), but
also normalized morphology and proliferation of HaCaT cells that
were found abnormally changed in the serum-free medium.
In addition to induction of ultrastructure changes in cultured
keratinocytes, shortening and rarefication of desmosomes, formation
of numerous regularly spaced microvilli, widening of intercellular
spaces, and cell membrane retraction with loss of microvilli and cell-
to-cell contact (Barnett and Szabo, 1973), regulation of epithelial cell
proliferation (Varani et al, 1989; Zouboulis et al, 1993), and
enhancement of keratin 19 expression in vivo and in vitro (Gilfix
and Eckert, 1985; Regnier et al, 1989), retinoids have been shown
to regulate CRABP II mRNA levels in human epidermis (Elder
et al, 1993; Kang et al, 1995; Zouboulis et al, 1996). Induction of
CRABP II mRNA levels has been suggested to be an early event
of retinoid signaling. We confirmed previous results showing that
human keratinocytes in vitro present low CRABP II mRNA levels
in early confluence that increase with culture duration (Elder et al,
1992), but to our knowledge, this is the first work reporting the
induction of CRABP II mRNA levels by retinoids in cultured
human keratinocytes. Interestingly, RA-induced CRABP II
mRNA levels decreased with time. CRABP II function is still
unknown, but it has been suggested that CRABP II mRNA levels
are indicative of cellular RA amounts. CRABP II may assist in
reducing the free RA levels available to reach the nucleus, and/or
act as a cofactor in RA metabolism regulating the bioavailability
of active retinoids (Siegenthaler and Saurat, 1991; Napoli et al, 1995).
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